Virus associated hemaphagocytic syndrome (VAHS)

Specialty: Hematology


IVIG is not recommended for routine use in the treatment of VAHS. IVIG may be considered among the options for treatment of severe life threatening VAHS.


No recommended dose or duration listed; however, expert panel recommends up to 2 g/kg divided over 2 to 5 consecutive days.